Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05835518 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05835518 · ClinicalTrials.gov record · last posted 2023-05-09

An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS

Name: An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS — clinical trial record (NCT05835518)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot specified

SponsorYuhan Corporation

Started2023-01-26

View on ClinicalTrials.gov ↗

Record status

This record was last updated May 9, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

from the ClinicalTrials.gov record

This Study is to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis, An Observational, Prospective Study

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2023-04-18. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details

NCT Number	NCT05835518
Lead Sponsor	Yuhan Corporation
Conditions	Rheumatoid Arthritis, Ankylosing Spondylitis
Enrollment	1,000 participants
Start Date	2023-01-26
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2023-05-09